fda approvals in sclc and a biosimilar, and japanese approvals in aml, ntrk tumors, and more
Published 5 years ago • 167 plays • Length 10:01
Download video MP4
Download video MP3
Similar videos
-
8:51
fda approvals in nets, breast cancer, aml, a biosimilar, and more
-
8:30
fda approvals in bladder cancer, nsclc, aml, hcc, and a breakthrough designation in nsclc
-
8:21
fda approval of a biosimilar, priority review in epithelioid sarcoma, and more
-
9:35
fda approvals in breast cancer and of a biosimilar, nda submitted in cll, and more
-
9:29
fda approvals in all and breast cancer, priority reviews in cml and follicular lymphoma, and more
-
10:23
fda approvals in hematologic malignancies, sbla accepted in multiple myeloma, and more
-
5:21
fda approvals in cll and all, nda accepted in melanoma, and more
-
1:08
dr. horn on the fda approval of atezolizumab plus bevacizumab and chemotherapy in nsclc
-
4:59
hanging drop method
-
13:43
how to help a friend with cancer | christopher gorelik | tedxoakschristianschool
-
3:07
npm1 mutated acute myeloid leukaemia
-
9:25
fda approvals in large b-cell lymphoma and melanoma, priority reviews in cscc and nsclc, and more
-
12:53
fda approval in sclc, partial hold in myeloma trials, nccn guideline update in crc, and more
-
10:46
fda approval in all, priority reviews in cml and breast cancer, and more
-
7:23
fda approval in nsclc, priority review in sclc, 2018 sabcs highlights, and more
-
7:44
fda approvals for daratumumab and osimertinib, regulatory advances in rcc and cll, and more
-
7:28
fda approvals in pml, nsclc, and breast cancer, priority review in dlbcl, and more
-
2:26
overview of 4 fda approvals in acute myeloid leukemia
-
7:05
the fda approval of atezolizumab in bladder cancer
-
9:46
fda approval in cll, recommendation in nsclc, missed endpoint in gbm study, and more
-
7:18
full fda approvals in breast cancer and lung cancer, priority reviews in all, and more
-
1:27
fda approval of atezolizumab for nsclc
Clip.africa.com - Privacy-policy